Extracted from: Cortex of Salix alba (Willow)
Content: 1.160 ml
Packaged: Plastic container and box.
Uses supported by clinical data
Used orally for the symptomatic treatment of fever and pain, and symptomatic treatment of mild rheumatic conditions.
Cortex Salicis is contraindicated in cases of hypersensitivity or allergy to the plant material or to salicylates (e.g. asthma, bronchial spasm, rhinitis or urticaria).
It is also contraindicated during pregnancy and lactation, in patients with salicylate intolerance and patients with impaired thrombocyte function, and in children under the age of 12 years.
In children under the age of 12 years, Cortex Salicis should only be used on the advice of a health care professional due to the possibility of Reye’s syndrome. In cases of a child or adolescent who has become very ill with severe vomiting, drowsiness or loss of consciousness following a viral infection, Reye’s syndrome should be suspected. This extremely rare, lifethreatening disease requires immediate medical attention. In cases of severe liver or renal dysfunction, coagulation disorders, gastric/duodenal ulcer and glucose-6-phosphate dehydrogenase deficiency, the product should only be taken under medical supervision. Consult a health care professional in cases of fever (> 39 C), lasting longer than 3 days. A health care professional should also be consulted if acute conditions of swelling of joints, redness and impaired mobility persist or worsen during the first week of use of Cortex Salicis.